FLIM-FRET Measurements of Protein-Protein Interactions in Live Bacteria.
August 25th, 2020
9.5K views
We describe here a protocol to characterize protein-protein interactions between two highly-differently expressed proteins in live Pseudomonas aeruginosa using FLIM-FRET measurements. The protocol includes bacteria strain constructions, bacteria immobilization, imaging and post-imaging data analysis routines.
Overview
This study presents a protocol for characterizing protein-protein interactions in live Pseudomonas aeruginosa through FLIM-FRET measurements. The approach focuses on analyzing interactions between two proteins expressed at significantly different levels within the native cellular environment.
Key Study Components
Research Area
- Protein-protein interactions
- Live cell imaging
- Molecular biology techniques
Background
- The necessity of studying protein interactions in native cellular contexts.
- FLIM-FRET as an advanced method for investigating these interactions.
- Challenges in analyzing unbalanced donor and acceptor protein ratios.
Methods Used
- FLIM-FRET measurements
- Pseudomonas aeruginosa as the biological model organism
- Data acquisition and analysis using microscopy and RStudio
Main Results
- Demonstrated successful identification of protein interactions in live cells.
- Established that differences in protein expression levels can affect FRET efficiency.
- Provided insights into the stoichiometry of proteins and their interactions.
Conclusions
- The study validates the use of FLIM-FRET for probing protein interactions in living systems.
- Findings contribute to the understanding of molecular interactions crucial for cellular processes.
Frequently Asked Questions
What is FLIM-FRET?
FLIM-FRET is a technique used to measure protein-protein interactions in live cells by analyzing fluorescence lifetime changes.
Why is studying protein-protein interactions important?
Protein-protein interactions are vital for understanding cellular processes and signaling pathways, affecting function and regulation.
What organisms were used in this study?
Pseudomonas aeruginosa was the primary organism used for the experiments.
How can unbalanced donor and acceptor ratios affect results?
Unbalanced ratios can lead to inaccurate interpretations of FRET data, impacting the understanding of molecular interactions.
What software was utilized for data analysis?
RStudio was used to perform statistical analysis on the collected FLIM-FRET data.
Can FLIM-FRET be used for other biological systems?
Yes, FLIM-FRET can potentially be applied to various systems beyond Pseudomonas aeruginosa to study protein interactions.
What is the significance of the findings?
The findings enhance the understanding of protein interactions in living cells, which are essential for cellular function and signaling.
Executive Industry Relevance
FLIM-FRET enables quantitative assessment of protein-protein interactions in live bacterial systems, providing mechanistic insights critical for target validation in antimicrobial discovery. By measuring fluorescence lifetime decay at single-cell resolution, the technique supports de-risking of therapeutic hypotheses involving PPIs in pathogenic models like Pseudomonas aeruginosa. This capability enhances predictive confidence in early discovery by revealing spatial and stoichiometric features of interactions under native expression conditions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by confirming suspected PPIs in live cells with native protein expression levels.
- Operational Value: Provides quantitative, spatially resolved data on interaction efficiency independent of concentration artifacts.
- Predictive Value: Supports biological de-risking through direct observation of interaction dynamics in relevant pathogen models.
Screening & Assay Development
- Scientific Value: Generates robust fluorescence lifetime distributions that distinguish specific interactions from random collisions.
- Operational Value: Enables standardization of PPI assays using FLIM readouts less susceptible to intensity-based artifacts.
- Scalability: Compatible with microscopy facilities increasingly adopting FLIM, supporting broader assay implementation.
Translational & Preclinical Research
- Translational Continuity: Bridges discovery findings to preclinical validation by confirming PPIs in live, pathogenic bacterial contexts.
- Mechanistic De-risking: Clarifies whether observed PPIs occur at biologically relevant distances, avoiding false positives from mere co-localization.
- Stoichiometry Insight: Reveals binding ratios (e.g., 1:1 or multiple donors per acceptor) critical for modeling inhibition strategies.
Pipeline & Workflow Integration
FLIM-FRET fits within the discovery continuum from target hypothesis testing to lead optimization, particularly for antimicrobial programs requiring validation of PPIs in native pathogen environments.
- Discovery Biology: Supports hypothesis-driven validation of PPIs by providing direct evidence of interaction in live cells under near-physiological expression.
- Assay Readiness: Delivers quantitative lifetime measurements enabling comparison across mutants, conditions, or therapeutic perturbations.
- Analytics Output: Generates empirical cumulative distribution functions and tau/alpha parameters for objective interaction scoring.
- Translational Relevance: Maintains continuity from in vitro interaction predictions to confirmation in live Pseudomonas aeruginosa, a model for persistent infections.
- Enterprise Reuse: Establishes a transferable imaging and analysis workflow applicable across bacterial strains and protein pairs.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity by distinguishing true PPIs from spectral overlap or overexpression artifacts.
- Operational Value: Promotes reproducibility through lifetime-based metrics resistant to variations in excitation intensity or fluorophore concentration.
- Strategic Value: Informs go/no-go decisions by validating target engagement in pathogenic models prior to compound screening.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on confirmed, quantifiable PPIs in disease-relevant systems.
Implementation Considerations
- Requires expertise in fluorescence microscopy, FLIM hardware operation, and photon-counting detector management.
- Dependent on access to FLIM-capable systems and stable laser sources (e.g., 930 nm) for controlled excitation.
- Necessitates standardized sample preparation to ensure bacterial immobilization and consistent agarose pad quality.
- Involves adaptation of labeling strategies to accommodate large expression differences between interacting proteins.
- Demands careful optimization of laser power and acquisition time to avoid photon pileup while maintaining sufficient signal for lifetime fitting.
Biopharma FAQs
Why does fluorescence lifetime measurement matter for PPI validation?
Fluorescence lifetime measurements in FLIM-FRET provide a quantitative, concentration-independent readout of protein-protein interactions, enabling accurate detection of energy transfer even when donor and acceptor expression levels are highly unbalanced, which is common in native bacterial systems.
How does isolating the donor fluorescence signal improve interaction analysis?
By isolating the donor fluorescence emission path and measuring its lifetime decay, FLIM-FRET avoids complications from direct acceptor excitation or bleed-through, ensuring that observed lifetime changes are solely due to FRET and thus reflect genuine molecular interactions.
What quantitative output enables discrimination between specific and nonspecific interactions?
The empirical cumulative distribution function of fluorescence lifetimes, when shifted toward shorter lifetimes, indicates FRET occurrence and specific binding, while absence of shift suggests no interaction or excessive fluorophore separation preventing energy transfer.
Why are replication requirements essential for FLIM-FRET data interpretation?
Replication across multiple cells and conditions is necessary to account for biological variability and stochastic expression differences, ensuring that observed lifetime shifts represent consistent interaction patterns rather than outliers in heterogeneous bacterial populations.
What statistical capability is needed to interpret FLIM-FRET lifetime distributions?
The ability to fit lifetime components (e.g., tau and alpha values) and compare empirical cumulative distribution functions is required to quantify FRET efficiency, assess stoichiometry, and distinguish between 1:1 and complex binding models in the data.
